home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Stopping DNA Synthesis Before It Starts

  May, 15 2008 10:15
your information resource in human molecular genetics

A small-molecule inhibitor of Cdc7 kinase prevents DNA synthesis and has antitumour activity, suggests a paper online in Nature Chemical Biology. The finding could help scientists develop methods of treating tumours with less toxicity than is associated with related anticancer drugs currently in clinical use.

One characteristic of cancer cells is uncontrolled cell division, and many widely used -- and quite toxic -- anticancer drugs work by interfering with later stages of DNA replication. Cdc7 works at the very early stages of DNA replication by activating a group of proteins clustered at 'origins of replication', thus initiating DNA synthesis.

To see if preventing the initiation of DNA synthesis would be an effective and less toxic approach to chemotherapeutics, Corrado Santocanale and colleagues identified a potent inhibitor of Cdc7. In mouse studies, the inhibitor reduced tumor size with relatively low levels of toxicity, thus validating Cdc7 as an anticancer target. This new inhibitor will also be important in investigating the role of Cdc7 in cell division and cancer.

Author contact:

Corrado Santocanale, (National University of Ireland Galway, Galway, Ireland)
Email: corrado.santocanale@nuigalway.ie

Abstract available online.

(C) Nature Chemical Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.